| Cash Flow | 2025-03-31 |
|---|---|
| Investment (income) loss, net | 6,500 |
| Loss on financial instruments, net (related party of 552 and 67,457) | 2,242 |
| Provision for credit losses | 1,000 |
| Loss on impairment of goodwill | 3,692 |
| Accrual (release) of loss contingency related to arbitration award | -54,973 |
| (gain) loss on liability resolution | -23,462 |
| Loss on extinguishment of debt | - |
| Net income (loss) | -803 |
| Depreciation and amortization | 1,695 |
| Net amortization of debt premium and discount (related party of 296 and (1,849)) | 296 |
| Non cash interest expense (related party of 9,715 and 9,463) | 12,214 |
| Non cash interest income | -494 |
| Non cash share-based compensation | 5,649 |
| Provision for deferred taxes | 80 |
| Changes in other assets | -32,784 |
| Changes in accounts payable and accrued expenses | 41,445 |
| Changes in other liabilities and deferred revenue | - |
| Net cash used in operating activities | -37,703 |
| Return of investments in alternative assets held by customer exalt trusts | 30,368 |
| Purchase of investments in alternative assets held by customer exalt trusts | -1,219 |
| Purchase of premises and equipment | -1,099 |
| Proceeds from sale of put options by ben | - |
| Proceeds from sale of public equity securities held by customer exalt trusts | 55 |
| Net cash provided by investing activities | 28,105 |
| Proceeds from related party debt financings | 1,675 |
| Payments on related party debt financings, customer exalt trust loan payable | -4,675 |
| Proceeds from issuance of convertible debt | 3,575 |
| Payments on convertible debt | -4,000 |
| Redemption of preferred series b subclass 2 unit accounts-Preferred Series BSubclass2 | - |
| Proceeds received from issuance of class a common under standby equity purchase agreement | 7,859 |
| Payment of deferred financing costs for debt | - |
| Payment of deferred financing costs for equity | -2,140 |
| Distribution to noncontrolling interest | - |
| Proceeds from sale of class a common shares | 673 |
| Payment of employee income taxes on restricted equity units | - |
| Proceeds from de-spac merger | - |
| Payment for prepaid forward purchase agreement | - |
| Net cash provided by financing activities | 2,967 |
| Net decrease in cash, cash equivalents, and restricted cash | -6,631 |
| Cash and cash equivalents at beginning of period | 7,977 |
| Cash and cash equivalents at end of period | 1,346 |
Beneficient (BENF)
Beneficient (BENF)